1887
  1. Home
  2. Eurosurveillance
  3. Volume 26, Issue 31, 05/Aug/2021
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

Several studies report high effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe disease, however an important knowledge gap is the vaccine effectiveness against transmission (VET). We present estimates of the VET to household and other close contacts in the Netherlands, from February to May 2021, using contact monitoring data. The secondary attack rate among household contacts was lower for fully vaccinated than unvaccinated index cases (11% vs 31%), with an adjusted VET of 71% (95% confidence interval: 63–77).

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.31.2100640
2021-08-05
2024-12-11
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.31.2100640
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/31/eurosurv-26-31-2.html?itemId=/content/10.2807/1560-7917.ES.2021.26.31.2100640&mimeType=html&fmt=ahah

References

  1. de Gier B, de Oliveira Bressane Lima P, van Gaalen RD, de Boer PT, Alblas J, Ruijten M, et al. Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020. Euro Surveill. 2020;25(50):2001884.  https://doi.org/10.2807/1560-7917.ES.2020.25.50.2001884  PMID: 33334396 
  2. Center for Infectious Disease Control. Protocol bron- en contactonderzoek COVID-19. [Protocol source and contact tracing]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 8 July 2021. Dutch. Available from: https://lci.rivm.nl/COVID-19-bco
  3. Snijders BEP, van Lier A, van de Kassteele J, Fanoy EB, Ruijs WLM, Hulshof F, et al. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine. 2012;30(19):2999-3002.  https://doi.org/10.1016/j.vaccine.2012.02.035  PMID: 22381073 
  4. Halloran ME, Préziosi M-P, Chu H. Estimating vaccine efficacy from secondary attack rates. J Am Stat Assoc. 2003;98(461):38-46.  https://doi.org/10.1198/016214503388619076 
  5. Harris RJ, Hall JA, Zaidi A, Andrews NJ, Dunbar JK, Dabrera G. Impact of vaccination on household transmission of SARS-COV-2 in England. London: Knowledge Hub; 2021. Available from: https://khub.net/documents/135939561/390853656/Impact+of+vaccination+on+household+transmission+of+SARS-COV-2+in+England.pdf/35bf4bb1-6ade-d3eb-a39e-9c9b25a8122a?t=1619551571214
  6. Shah AS, Gribben C, Bishop J, Hanlon P, Caldwell D, Wood R, et al. Effect of vaccination on transmission of COVID-19: an observational study in healthcare workers and their households. medRxiv. 2021:2021.03.11.21253275.
  7. Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, et al. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Euro Surveill. 2021;26(21):2100438.  https://doi.org/10.2807/1560-7917.ES.2021.26.21.2100438  PMID: 34047271 
  8. Halloran ME, Haber M, Longini IM Jr, Struchiner CJ. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol. 1991;133(4):323-31.  https://doi.org/10.1093/oxfordjournals.aje.a115884  PMID: 1899778 
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Brechje+de+Gier&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Gier Brechje</a>, <a href="/search?value1=Stijn+Andeweg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Andeweg Stijn</a>, <a href="/search?value1=Rosa+Joosten&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Joosten Rosa</a>, <a href="/search?value1=Ronald+ter+Schegget&option1=author&noRedirect=true" class="nonDisambigAuthorLink">ter Schegget Ronald</a>, <a href="/search?value1=Naomi+Smorenburg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Smorenburg Naomi</a>, <a href="/search?value1=Jan+van+de+Kassteele&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van de Kassteele Jan</a>, <a href="/search?value1=RIVM+COVID-19+surveillance+and+epidemiology+team+1%2C&option1=author&noRedirect=true" class="nonDisambigAuthorLink">RIVM COVID-19 surveillance and epidemiology team 1,</a>, <a href="/search?value1=Susan+JM+Hahn%C3%A9&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hahné Susan JM</a>, <a href="/search?value1=Susan+van+den+Hof&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van den Hof Susan</a>, <a href="/search?value1=Hester+E+de+Melker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Melker Hester E</a>, <a href="/search?value1=Mirjam+J+Knol&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Knol Mirjam J</a></span>. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021. <a href="/content/ecdc">Euro Surveill.</a> 2021;26(31):pii=2100640. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.31.2100640" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2021.26.31.2100640</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 29 Jun 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 02 Aug 2021 </span> </p>
/content/10.2807/1560-7917.ES.2021.26.31.2100640
/content/10.2807/1560-7917.ES.2021.26.31.2100640
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error